Portside Wealth Group LLC Grows Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Portside Wealth Group LLC grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.2% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,009 shares of the medical equipment provider’s stock after purchasing an additional 110 shares during the period. Portside Wealth Group LLC’s holdings in Intuitive Surgical were worth $449,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Creekmur Asset Management LLC lifted its position in Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 42 shares during the last quarter. MCF Advisors LLC increased its stake in shares of Intuitive Surgical by 108.1% during the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 40 shares during the period. Able Wealth Management LLC acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $28,000. Delos Wealth Advisors LLC raised its holdings in Intuitive Surgical by 380.0% in the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 57 shares in the last quarter. Finally, MeadowBrook Investment Advisors LLC acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

ISRG has been the topic of a number of analyst reports. BTIG Research raised their price objective on shares of Intuitive Surgical from $451.00 to $459.00 and gave the company a “buy” rating in a report on Monday, July 15th. Citigroup boosted their target price on Intuitive Surgical from $462.00 to $512.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. Truist Financial raised their price objective on shares of Intuitive Surgical from $450.00 to $515.00 and gave the stock a “buy” rating in a report on Tuesday, July 16th. Evercore ISI lowered their target price on shares of Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating for the company in a report on Friday, July 19th. Finally, Robert W. Baird lifted their price target on shares of Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a research note on Friday, July 19th. Six investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $442.30.

Insider Transactions at Intuitive Surgical

In other news, Director Craig H. Barratt sold 2,496 shares of the stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $402.89, for a total transaction of $1,005,613.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Intuitive Surgical news, Director Craig H. Barratt sold 2,496 shares of the company’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $402.89, for a total transaction of $1,005,613.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Amal M. Johnson sold 2,943 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at $5,441,507.50. The disclosure for this sale can be found here. Insiders have sold 15,309 shares of company stock valued at $6,642,470 in the last quarter. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Down 0.2 %

ISRG traded down $1.19 on Friday, reaching $478.98. The company had a trading volume of 809,102 shares, compared to its average volume of 1,553,632. The company has a market capitalization of $169.89 billion, a P/E ratio of 86.46, a PEG ratio of 4.97 and a beta of 1.39. The company has a fifty day moving average of $443.20 and a 200-day moving average of $407.46. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $482.50.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The business had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $1.97 billion. During the same quarter last year, the business posted $1.18 earnings per share. The company’s quarterly revenue was up 14.5% on a year-over-year basis. Research analysts predict that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.